Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

320.42

+1.51 (0.47%)

At close: Mar 17, 2026, 4:00 PM EDT

320.14

-0.28 (-0.09%)

After-hours: Mar 17, 2026, 5:43 PM EDT

Alnylam Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,657	966.43	812.69	866.39	819.98
Short-Term Investments	1,251	1,728	1,627	1,326	1,616
Cash & Short-Term Investments	2,908	2,695	2,439	2,192	2,436
Cash Growth	7.94%	10.46%	11.27%	-9.98%	29.94%
Accounts Receivable	777.57	405.31	327.79	237.96	198.57
Inventory	82.72	78.51	89.15	128.96	86.36
Other Current Assets	281.89	116.96	126.38	132.92	88.08
Total Current Assets	4,051	3,295	2,983	2,692	2,809
Net Property, Plant & Equipment	708.06	693.93	725.79	738.63	733.63
Other Long-Term Assets	207.61	250.77	121.39	115.48	101.1
Total Assets	4,966	4,240	3,830	3,546	3,643
Accounts Payable	115.72	88.42	55.52	98.09	73.43
Accrued Expenses	1,080	793.69	713.01	545.46	395.17
Current Portion of Leases	45.52	41.89	41.51	41.97	40.55
Unearned Revenue	4.85	55.48	102.75	42.11	149.48
Other Current Liabilities	220.07	206.8	54.99	40.29	37.08
Total Current Liabilities	1,466	1,186	967.79	767.92	695.71
Long-Term Debt	1,008	1,025	1,021	1,017	675.7
Long-Term Leases	225.09	229.54	243.1	261.34	281.35
Other Long-Term Liabilities	1,478	1,732	1,819	1,658	1,402
Total Long-Term Liabilities	2,711	2,987	3,083	2,937	2,359
Total Liabilities	4,177	4,173	4,051	3,705	3,055
Common Stock	1.32	1.29	1.26	1.24	1.2
Additional Paid-in Capital	7,510	7,388	6,811	6,455	6,058
Accumulated Other Comprehensive Income	-20.1	-34.52	-23.38	-44.65	-33.26
Retained Earnings	-6,703	-7,288	-7,010	-6,569	-5,438
Shareholders' Equity	789.18	67.09	-220.64	-158.22	588.2
Total Liabilities & Equity	4,966	4,240	3,830	3,546	3,643
Total Debt	1,278	1,296	1,305	1,320	997.59
Net Cash (Debt)	1,630	1,398	1,134	872.16	1,438
Net Cash Growth	16.56%	23.32%	30.02%	-39.35%	6.26%
Net Cash Per Share	12.10	10.96	9.08	7.17	12.14
Book Value	789.18	67.09	-220.64	-158.22	588.2
Book Value Per Share	5.86	0.53	-1.77	-1.30	4.97
Tangible Book Value	789.18	67.09	-220.64	-158.22	588.2
Tangible Book Value Per Share	5.86	0.53	-1.77	-1.30	4.97

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q